Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Current Leases (2020 - 2025)

Benitec Biopharma has reported Current Leases over the past 6 years, most recently at $468000.0 for Q4 2025.

  • Quarterly results put Current Leases at $468000.0 for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $468000.0 (changed N/A YoY), and the annual figure for FY2025 was $354000.0, up 24.65%.
  • Current Leases reached $468000.0 in Q4 2025 per BNTC's latest filing, up from $414000.0 in the prior quarter.
  • Across five years, Current Leases topped out at $468000.0 in Q4 2025 and bottomed at $194000.0 in Q3 2021.
  • Median Current Leases over the past 5 years was $269000.0 (2023), compared with a mean of $279578.9.
  • The largest annual shift saw Current Leases fell 24.64% in 2024 before it soared 96.21% in 2025.
  • Over 5 years, Current Leases stood at $213000.0 in 2021, then increased by 23.47% to $263000.0 in 2022, then grew by 8.75% to $286000.0 in 2023, then fell by 26.22% to $211000.0 in 2024, then soared by 121.8% to $468000.0 in 2025.
  • Business Quant data shows Current Leases for BNTC at $468000.0 in Q4 2025, $414000.0 in Q3 2025, and $354000.0 in Q2 2025.